MedGenome looks to market novel screening test for coronary artery disease

Until now people who feared coronary artery disease (CAD) could walk into a hospital and get a blood test, cholesterol check-up or an electrocardiogram done to get the health of the heart checked. Going a step ahead in checking the health of one's heart, Sequoia-backed genomics-based diagnostics company MedGenome Labs has rolled out a statistical method called Polygenic Risk Score (PRS) for a first time in India. The test calculates one's risk of developing an artery blockage based on the millions of genetic variations in his anatomy.

“While other screening methods pick up the risk of an artery blockage a few